the optimum treatment regimen in both normal and cyclophosphamide-treated mice was intraperitoneal administration of 100 ng of rhuil-1 beta or 1.6 mg of [ abu1 ] mdp per mouse once daily for 3 consecutive days before infection .
C0021753
rhuil-1 beta
C0086418
rhuil-1 beta